scholarly article | Q13442814 |
P50 | author | Raymond P. Donnelly | Q40102325 |
Adelle P McFarland | Q56839862 | ||
Stefania Pittaluga | Q87358458 | ||
Wyndham H. Wilson | Q110350523 | ||
Kieron Dunleavy | Q114521842 | ||
P2093 | author name string | Lionel Feigenbaum | |
Dennis M Klinman | |||
Ram Savan | |||
Hidekazu Shirota | |||
Stephen K Anderson | |||
Howard A Young | |||
Della A Reynolds | |||
Karthika Ramakrishnan | |||
Megan Karwan | |||
P2860 | cites work | Interleukin (IL)-22, a novel human cytokine that signals through the interferon receptor-related proteins CRF2-4 and IL-22R | Q22254431 |
IL-21 is produced by Th17 cells and drives IL-17 production in a STAT3-dependent manner | Q24644925 | ||
Phase II study of dose-adjusted EPOCH and rituximab in untreated diffuse large B-cell lymphoma with analysis of germinal center and post-germinal center biomarkers | Q24646379 | ||
Structure of IL-22 bound to its high-affinity IL-22R1 chain | Q24656543 | ||
T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines | Q24678115 | ||
Effective therapy of murine models of human leukemia and lymphoma with radiolabeled anti-CD30 antibody, HeFi-1 | Q24685212 | ||
Anaplastic lymphoma kinase (ALK) activates Stat3 and protects hematopoietic cells from cell death | Q28202067 | ||
Molecular signatures to improve diagnosis in peripheral T-cell lymphoma and prognostication in angioimmunoblastic T-cell lymphoma | Q33634415 | ||
Identification of the functional interleukin-22 (IL-22) receptor complex: the IL-10R2 chain (IL-10Rbeta ) is a common chain of both the IL-10 and IL-22 (IL-10-related T cell-derived inducible factor, IL-TIF) receptor complexes | Q33921809 | ||
Pathobiology of NPM-ALK and variant fusion genes in anaplastic large cell lymphoma and other lymphomas | Q34037769 | ||
Neutrophil recruitment by human IL-17 via C-X-C chemokine release in the airways | Q34492076 | ||
Effective therapy for a murine model of human anaplastic large-cell lymphoma with the anti-CD30 monoclonal antibody, HeFi-1, does not require activating Fc receptors | Q35848928 | ||
Autocrine release of interleukin-9 promotes Jak3-dependent survival of ALK+ anaplastic large-cell lymphoma cells | Q35849172 | ||
What have we learnt from mouse models of NPM-ALK-induced lymphomagenesis? | Q36132014 | ||
Aberrant expression of IL-22 receptor 1 and autocrine IL-22 stimulation contribute to tumorigenicity in ALK+ anaplastic large cell lymphoma | Q36193920 | ||
The anaplastic lymphoma kinase in the pathogenesis of cancer | Q37039605 | ||
IL-21 contributes to JAK3/STAT3 activation and promotes cell growth in ALK-positive anaplastic large cell lymphoma | Q37278507 | ||
Extreme neutrophil granulocytosis in a patient with anaplastic large cell lymphoma of T-cell lineage. | Q40448136 | ||
Genomic structure and inducible expression of the IL-22 receptor alpha chain in mice | Q40666390 | ||
Interleukin-22 (IL-22) activates the JAK/STAT, ERK, JNK, and p38 MAP kinase pathways in a rat hepatoma cell line. Pathways that are shared with and distinct from IL-10. | Q40721858 | ||
Lack of involvement of the c-fms and N-myc genes by chromosomal translocation t(2;5)(p23;q35) common to malignancies with features of so-called malignant histiocytosis. | Q42814341 | ||
A Ki-1 (CD30)-positive human cell line (Karpas 299) established from a high-grade non-Hodgkin's lymphoma, showing a 2;5 translocation and rearrangement of the T-cell receptor beta-chain gene | Q44270446 | ||
Jak3 activation is significantly associated with ALK expression in anaplastic large cell lymphoma | Q46695204 | ||
Mice lacking granulocyte colony-stimulating factor have chronic neutropenia, granulocyte and macrophage progenitor cell deficiency, and impaired neutrophil mobilization | Q52507472 | ||
Antiapoptotic activity of autocrine interleukin-22 and therapeutic effects of interleukin-22-small interfering RNA on human lung cancer xenografts. | Q54512003 | ||
Neutrophil-rich anaplastic large cell lymphoma (NR-ALCL) mimicking lymphadenitis: a study by fine-needle aspiration biopsy | Q80549121 | ||
Jak3 contributes to the activation of ALK and Stat3 in ALK(+) anaplastic large cell lymphoma | Q82917953 | ||
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | inflammation | Q101991 |
P304 | page(s) | 575-584 | |
P577 | publication date | 2010-10-22 | |
P1433 | published in | Blood | Q885070 |
P1476 | title | A novel role for IL-22R1 as a driver of inflammation | |
P478 | volume | 117 |
Q38170180 | A tale of two cytokines: IL-17 and IL-22 in asthma and infection |
Q47631823 | ALK is a therapeutic target for lethal sepsis. |
Q46178702 | An Exploration into the Origins and Pathogenesis of Anaplastic Large Cell Lymphoma, Anaplastic Lymphoma Kinase (ALK)-Positive |
Q54371901 | Anaplastic large cell lymphoma with paraneoplastic neutrophilia: an association between IL-17 elevation and aggressive disease progression. |
Q49837454 | Blood cytokine concentrations in pediatric patients with anaplastic lymphoma kinase-positive anaplastic large cell lymphoma |
Q47390109 | Cancer cells induce interleukin-22 production from memory CD4+ T cells via interleukin-1 to promote tumor growth |
Q90695381 | Cell of Origin and Immunologic Events in the Pathogenesis of Breast Implant-Associated Anaplastic Large-Cell Lymphoma |
Q45996759 | Clinical analysis and prognostic significance of haemophagocytic lymphohistiocytosis-associated anaplastic large cell lymphoma in children. |
Q37994612 | Cytokine-based therapy in psoriasis |
Q57174069 | Dependency on the TYK2/STAT1/MCL1 axis in anaplastic large cell lymphoma |
Q35133818 | Endogenous IL-22 plays a dual role in arthritis: regulation of established arthritis via IFN-γ responses |
Q34454590 | Genetic polymorphisms and tissue expression of interleukin-22 associated with risk and therapeutic response of gastric mucosa-associated lymphoid tissue lymphoma |
Q36658484 | Genetics of Bladder Malignant Tumors in Childhood |
Q38081171 | IL-22, not simply a Th17 cytokine |
Q54981113 | Immune Response against ALK in Children with ALK-Positive Anaplastic Large Cell Lymphoma. |
Q35074604 | In vivo consequences of liver-specific interleukin-22 expression in mice: Implications for human liver disease progression |
Q36531638 | Increased expressions of IL-22 and Th22 cells in the coxsackievirus B3-Induced mice acute viral myocarditis |
Q38325566 | Innate lymphoid cells involve in tumorigenesis. |
Q53542274 | Interleukin (IL)-22 receptor 1 is over-expressed in primary Sjogren's syndrome and Sjögren-associated non-Hodgkin lymphomas and is regulated by IL-18. |
Q39314776 | Interleukin 17 is a chief orchestrator of immunity |
Q43102028 | Interleukin-22 binding protein (IL-22BP) is constitutively expressed by a subset of conventional dendritic cells and is strongly induced by retinoic acid |
Q26752528 | Interleukin-22 in Graft-Versus-Host Disease after Allogeneic Stem Cell Transplantation |
Q84365414 | Interleukin-22 promotes human hepatocellular carcinoma by activation of STAT3 |
Q38615132 | JAK2/STAT3 Pathway Was Associated with the Protective Effects of IL-22 On Aortic Dissection with Acute Lung Injury. |
Q34841987 | Kaposi's sarcoma-associated herpesvirus-encoded LANA down-regulates IL-22R1 expression through a cis-acting element within the promoter region |
Q38942795 | Metformin decreases IL-22 secretion to suppress tumor growth in an orthotopic mouse model of hepatocellular carcinoma |
Q91307598 | Molecular signature of interleukin-22 in colon carcinoma cells and organoid models |
Q42391532 | Nanovesicular liposome-encapsulated hemoglobin (LEH) prevents multi-organ injuries in a rat model of hemorrhagic shock |
Q39259618 | PDGFR blockade is a rational and effective therapy for NPM-ALK-driven lymphomas |
Q38366661 | Pivotal roles of ILCs in hepatic diseases |
Q41999154 | Pro-Inflammatory Signaling by IL-10 and IL-22: Bad Habit Stirred Up by Interferons? |
Q40193407 | Rapid label-free profiling of oral cancer biomarker proteins using nano-UPLC-Q-TOF ion mobility mass spectrometry |
Q52806518 | The AP-1-BATF and -BATF3 module is essential for growth, survival and TH17/ILC3 skewing of anaplastic large cell lymphoma. |
Q26799454 | The Newly Identified T Helper 22 Cells Lodge in Leukemia |
Q38184626 | The role of innate and lymphoid IL-22-producing cells in the immunopathology of primary Sjögren's syndrome. |